Off-Pump CABG surgery reduces systemic inflammation compared with on-pump surgery but does not change systemic endothelial responses: A prospective randomized study

Shock

Volumn 42, Issue 2, 2014, Pages 121-128

  Jongman, Rianne M ^a,b   Zijlstra, Jan G ^c   Kok, Wendelinde F ^a   Van Harten, Annemarie E ^a   Mariani, Massimo A ^b   Moser, Jill ^b,c   Struys, Michel M R F ^a   Absalom, Anthony R ^a   Molema, Grietje ^b   Scheeren, Thomas W L ^a   Van Meurs, Matijs ^b,c  

^a Departments of Anaesthesiology   (Netherlands)

^b UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^c Critical Care   (Netherlands)

Author keywords

CABG; Endothelial activation; microvascular flow; pulmonary bypass; systemic inflammation

Indexed keywords

INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 10; INTERLEUKIN 6; MYELOPEROXIDASE; TUMOR NECROSIS FACTOR ALPHA; VASCULAR CELL ADHESION MOLECULE 1; AUTACOID; CELL ADHESION MOLECULE; CYTOKINE;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; FEMALE; HUMAN; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; OFF PUMP CORONARY SURGERY; ON PUMP CORONARY SURGERY; PROTEIN BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL; STERNUM; BLOOD; CARDIOPULMONARY BYPASS; CORONARY ARTERY DISEASE; METABOLISM; PATHOPHYSIOLOGY; PROSPECTIVE STUDY; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; VASCULAR ENDOTHELIUM;

AGED; CARDIOPULMONARY BYPASS; CELL ADHESION MOLECULES; CORONARY ARTERY BYPASS; CORONARY ARTERY BYPASS, OFF-PUMP; CORONARY ARTERY DISEASE; CYTOKINES; ENDOTHELIUM, VASCULAR; FEMALE; HUMANS; INFLAMMATION MEDIATORS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME;

EID: 84904690156     PISSN: 10732322     EISSN: 15400514     Source Type: Journal    
DOI: 10.1097/SHK.0000000000000190     Document Type: Article

References (37)

1. Biglioli P, Cannata A, Alamanni F, Naliato M, Porqueddu M, Zanobini M, Tremoli E, Parolari A: Biological effects of off-pump vs. on-pump coronary artery surgery: focus on inflammation, hemostasis and oxidative stress. Eur J Cardiothorac Surg 24:260-269, 2003.
2. Warren OJ, Watret AL, de Wit KL, Alexiou C, Vincent C, Darzi AW, Athanasiou T: The inflammatory response to cardiopulmonary bypass: part 2-anti-inflammatory therapeutic strategies. J Cardiothorac Vasc Anesth 23: 384-393, 2009.
3. Onorati F, Rubino AS, Nucera S, Foti D, Sica V, Santini F, Gulletta E, Renzulli A: Off-pump coronary artery bypass surgery versus standard linear or pulsatile cardiopulmonary bypass: endothelial activation and inflammatory response. Eur J Cardiothorac Surg 37:897-904, 2010.
4. Maharaj C, Laffey JG: New strategies to control the inflammatory response in cardiac surgery. Curr Opin Anaesthesiol 17:35-48, 2004.
5. Aird WC: Endothelial cell heterogeneity. Crit Care Med 31:S221-S230, 2003.
6. Kayal S, Jais JP, Aguini N, Chaudiere J, Labrousse J: Elevated circulating Eselectin, intercellular adhesion molecule 1, and von Willebrand factor in patients with severe infection. Am J Respir Crit Care Med 157:776-784, 1998.
7. Turhan H, Saydam GS, Erbay AR, Ayaz S, Yasar AS, Aksoy Y, Basar N, Yetkin E: Increased plasma soluble adhesion molecules; ICAM-1, VCAM-1, and E-selectin levels in patients with slow coronary flow. Int J Cardiol 108:224-230, 2006.
8. Wei M, Laurikka J, Kuukasjarvi P, Pehkonen E, Tarkka M: Soluble adhesion molecules in coronary artery bypass surgery. Asian Cardiovasc Thorac Ann 11:198-202, 2003.
9. Wan IY, Arifi AA, Wan S, Yip JH, Sihoe AD, Thung KH, Wong EM, Yim AP: Beating heart revascularization with or without cardiopulmonary bypass: evaluation of inflammatory response in a prospective randomized study. J Thorac Cardiovasc Surg 127:1624-1631, 2004.
10. Andresen TK, Svennevig JL, Videm V: Soluble VCAM-1 is a very early marker of endothelial cell activation in cardiopulmonary bypass. Perfusion 17:15-21, 2002.
11. Wulfert FM, van Meurs M, Kurniati NF, Jongman RM, Houwertjes MC, Heeringa P, Struys MM, Zijlstra JG, Molema G: Age-dependent role of microvascular endothelial and polymorphonuclear cells in lipopolysaccharideinduced acute kidney injury. Anesthesiology 117:126-136, 2012.
12. Ascione R, Lloyd CT, Underwood MJ, Lotto AA, Pitsis AA, Angelini GD: Inflammatory response after coronary revascularization with or without cardiopulmonary bypass. Ann Thorac Surg 69:1198-1204, 2000.
13. van Meurs M, Kurniati NF, Wulfert FM, Asgeirsdottir SA, de Graaf IA, Satchell SC, Mathieson PW, Jongman RM, Kumpers P, Zijlstra JG, et al.: Shock-induced stress induces loss of microvascular endothelial Tie2 in the kidney which is not associated with reduced glomerular barrier function. Am J Physiol Renal Physiol 297:F272-F281, 2009.
14. Clajus C, Lukasz A, David S, Hertel B, Lichtinghagen R, Parikh SM, Simon A, Ismail I, Haller H, Kumpers P: Angiopoietin-2 is a potential mediator of endothelial barrier dysfunction following cardiopulmonary bypass. Cytokine 60:352-359, 2012.
15. Wada T, Jesmin S, Gando S, Sultana SN, Zaedi S, Yokota H: Using angiogenic factors and their soluble receptors to predict organ dysfunction in patients with disseminated intravascular coagulation associated with severe trauma. Crit Care 16:R63, 2012.
16. Augustin HG, Koh GY, Thurston G, Alitalo K: Control of vascular morphogenesis and homeostasis through the angiopoietin-Tie system. Nat Rev Mol Cell Biol 10:165-177, 2009.
17. Yano K, Liaw PC, Mullington JM, Shih SC, Okada H, Bodyak N, Kang PM, Toltl L, Belikoff B, Buras J, et al.: Vascular endothelial growth factor is an important determinant of sepsis morbidity and mortality. J Exp Med 203: 1447-1458, 2006.
18. Pickkers P, Sprong T, Eijk L, Hoeven H, Smits P, Deuren M: Vascular endothelial growth factor is increased during the first 48 hours of human septic shock and correlates with vascular permeability. Shock 24:508-512, 2005.
19. Orfanos SE, Kotanidou A, Glynos C, Athanasiou C, Tsigkos S, Dimopoulou I, Sotiropoulou C, Zakynthinos S, Armaganidis A, Papapetropoulos A, et al.: Angiopoietin-2 is increased in severe sepsis: correlation with inflammatory mediators. Crit Care Med 35:199-206, 2007.
20. Kumpers P, Hafer C, David S, Hecker H, Lukasz A, Fliser D, Haller H, Kielstein JT, Faulhaber-Walter R: Angiopoietin-2 in patients requiring renal replacement therapy in the ICU: relation to acute kidney injury, multiple organ dysfunction syndrome and outcome. Intensive Care Med 36: 462-470, 2010.
21. Shapiro NI, Yano K, Okada H, Fischer C, Howell M, Spokes KC, Ngo L, Angus DC, Aird WC: A prospective, observational study of soluble FLT-1 and vascular endothelial growth factor in sepsis. Shock 29:452-457, 2008.
22. Denizot Y, Leguyader A, Cornu E, Laskar M, Orsel I, Vincent C, Nathan N: Release of soluble vascular endothelial growth factor receptor-1 (sFlt-1) during coronary artery bypass surgery. J Cardiothorac Surg 2:38, 2007.
23. van Meurs M, Kumpers P, Ligtenberg JJ, Meertens JH, Molema G, Zijlstra JG: Bench-to-bedside review: Angiopoietin signalling in critical illnessVa future target? Crit Care 13:207, 2009.
24. Kurniati NF, van Meurs M, Vom Hagen F, Jongman RM, Moser J, Zwiers PJ, Struys MM, Westra J, Zijlstra JG, Hammes HP, et al.: Pleiotropic effects of angiopoietin-2 deficiency do not protect mice against endotoxin-induced acute kidney injury. Nephrol Dial Transplant 28:567-575, 2013.
25. Schneditz D, Putz-Bankuti C, Ribitsch W, Schilcher G: Correction of plasma concentrations for effects of hemoconcentration or hemodilution. ASAIO J 58:160-162, 2012.
26. van der Heijden M, van Nieuw Amerongen GP, van Hinsbergh VW, Groeneveld AB: The interaction of soluble Tie2 with angiopoietins and pulmonary vascular permeability in septic and nonseptic critically ill patients. Shock 33:263-268, 2010.
27. Parolari A, Camera M, Alamanni F, Naliato M, Polvani GL, Agrifoglio M, Brambilla M, Biancardi C, Mussoni L, Biglioli P, et al.: Systemic inflammation after on-pump and off-pump coronary bypass surgery: a one-month follow-up. Ann Thorac Surg 84:823-828, 2007.
28. Nashef SA, Roques F, Michel P, Gauducheau E, Lemeshow S, Salamon R: European system for cardiac operative risk evaluation (EuroSCORE). Eur J Cardiothorac Surg 16:9-13, 1999.
29. Allen SJ, McBride WT, McMurray TJ, Phillips AS, Penugonda SP, Campalani G, Young IS, Armstrong MA: Cell salvage alters the systemic inflammatory response after off-pump coronary artery bypass grafting surgery. Ann Thorac Surg 83:578-585, 2007.
30. Vallely MP, Bannon PG, Bayfield MS, Hughes CF, Kritharides L: Endothelial activation after coronary artery bypass surgery: comparison between on-pump and off-pump techniques. Heart Lung Circ 19:445-452, 2010.
31. Shapiro NI, Schuetz P, Yano K, Sorasaki M, Parikh SM, Jones AE, Trzeciak S, Ngo L, Aird WC: The association of endothelial cell signaling, severity of illness, and organ dysfunction in sepsis. Crit Care 14:R182, 2010.
32. van Meurs M, Wulfert FM, Knol AJ, De Haes A, Houwertjes M, Aarts LP, Molema G: Early organ-specific endothelial activation during hemorrhagic shock and resuscitation. Shock 29: 291-299, 2008.
33. Shapiro NI, Yano K, Sorasaki M, Fischer C, Shih SC, Aird WC: Skin biopsies demonstrate site-specific endothelial activation in mouse models of sepsis. J Vasc Res 46:495-502, 2009.
34. Kalawski R, Bugajski P, Smielecki J, Wysocki H, Olszewski R, More R, Sheridan DJ, Siminiak T: Soluble adhesion molecules in reperfusion during coronary bypass grafting. Eur J Cardiothorac Surg 14:290-295, 1998.
35. Afuwape AO, Feldmann M, Paleolog EM: Adenoviral delivery of soluble VEGF receptor 1 (sFlt-1) abrogates disease activity in murine collagen-induced arthritis. Gene Ther 10:1950-1960, 2003.
36. Lamy A, Devereaux PJ, Dorairaj P, Taggart DP, Hu S, Paolasso E, Straka Z, Piegas LS, Akar AR, Jain AR, et al.: Effects of off-pump and on-pump coronary-artery bypass grafting at 1 year. N Engl J Med 368:1179-1188, 2013.
37. Molema G: Heterogeneity in endothelial responsiveness to cytokines, molecular causes, and pharmacological consequences. Semin Thromb Hemost 36: 246-264, 2010.